Literature DB >> 67714

Development of an intravenous gamma-globulin with Fc activities. II. Reconversion of S-sulfonated human gamma-globulin into the original gamma-globulin.

Y Masuho, K Tomibe, T Watanabe, Y Fukumoto.   

Abstract

The reconversion of S-sulfonated antitetanus gamma-globulin (S-GG) into the original gamma-globulin was studied. S-sulfonate groups in S-GG could be converted into disulfide bonds in vitro. The conversion restored the greater part of both complement-fixing and skin-sensitizing activities. S-GG administered intravenously formed interchain disulfide bonds again in vivo, which was accompanied by restoration of the C-dependent passive hemolytic activity. Intravenous injection of S-GG did not cause a significant decrease in serum complement level.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 67714     DOI: 10.1111/j.1423-0410.1977.tb00648.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  8 in total

1.  Evaluation of immunoglobulin G preparations for anti-cytomegalovirus antibodies with reference to neutralizing antibody in the presence of complement.

Authors:  Y Eizuru; I Ueno; Y Minamishima
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

2.  Clinical trial of sulfonated immunoglobulin preparation for intravenous administration. I. Replacement therapy for primary immunodeficiency syndromes.

Authors:  N Kobayashi; N Gohya; S Matsumoto
Journal:  Eur J Pediatr       Date:  1981-05       Impact factor: 3.183

3.  Protective effects of S-sulfonated human gamma globulin against experimental infections in mice.

Authors:  H Tomioka; Y Iwamura; Y Suzuki; S Ohtomo; Y Hashimoto
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

Review 4.  [Therapeutic use of immunoglobulins in children (author's transl)].

Authors:  W H Hitzig
Journal:  Blut       Date:  1980-03

5.  Antipyretic activity of a human immunoglobulin preparation for intravenous use in an experimental model of fever in rabbits.

Authors:  M Iwata; T Shimozato; H Tokiwa; E Tsubura
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

6.  [Tolerance of a new intravenously applied immunoglobulin preparation and its effect on serum globulin levels].

Authors:  W Hansi; H Heimpel; S Barandun; O Lutz
Journal:  Infection       Date:  1982 Nov-Dec       Impact factor: 3.553

7.  Effect of immunoglobulin G (IgG) interchain disulfide bond cleavage on efficacy of intravenous immunoglobulin for immune thrombocytopenic purpura (ITP).

Authors:  Y Machino; H Ohta; E Suzuki; S Higurashi; T Tezuka; H Nagashima; J Kohroki; Y Masuho
Journal:  Clin Exp Immunol       Date:  2010-10-05       Impact factor: 4.330

8.  Prophylactic treatment with sulphonated immunoglobulin G attenuates development of mechanical allodynia-like response in mice with neuropathic pain.

Authors:  Wataru Yamamoto; Yasuhiro Itano; Tsunefumi Kobayashi; Daishiro Miura; Yoshinori Kasahara
Journal:  J Vet Med Sci       Date:  2015-08-29       Impact factor: 1.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.